Shop ACC / AHA / HFSA Heart Failure

Heart Failure

Published: April 2022
Print Copy Information:
  • 80 pages
  • Spiral Bound
  • 80# Aqueous Coating
  • 4.25" x 7.25"
  • Ships in 5 – 10 business days
A digital version of this pocket guide is available for FREE at this link
What's Inside
Bulk and Institutional Ordering
About the Authors
Additional Information
  • Overview
    • Top 10 Take-Home Messages
  • Assessment
  • Treatment
  • Tables
    • Stages of HF
    • Classification of HF by LVEF
    • Other Potential Nonischemic Causes of HF
    • Selected Potential Causes of Elevated Natriuretic Peptide Levels
    • Examples of Factors Implicating Possible Genetic Cardiomyopathy
    • Potential Barriers to Effective HF Self-Care and Example Interventions
    • Commonly Used Oral Diuretics in Treatment of Congestion for Chronic HF
    • Selected Prescription Medications That May Cause or Exacerbate HF
    • Drugs Commonly Used for HFrEF (Stage C HF)
    • Benefits of Evidence-Based Therapies for Patients With HFrEF
    • ESC Definition of Advanced HF
    • INTERMACS Profiles
    • Clinical Indicators of Advanced HF
    • Indications and Contraindications to Durable Mechanical Support
    • Intravenous Inotropic Agents Used in the Management of HF
    • Common Factors Precipitating HF Hospitalization With Acute Decompensated HF
    • Suggested Shock Clinical Criteria
    • Suggested Shock Hemodynamic Criteria
    • Society for Cardiovascular Angiography and Interventions (SCAI) Cardiogenic Shock Criteria
    • Important Components of a Transitional Care Plan
    • Most Common Co-Occurring Chronic Conditions Among Medicare Beneficiaries With HF (N=4,947,918), 2011
    • Risk of HF and Outcomes in Special Populations
    • Cancer Therapies Known to Be Associated With Cardiomyopathy
    • Risk Factors for Cancer Therapy–Related Cardiomyopathy
    • HF Management Strategies Across the Pregnancy Continuum
    • Palliative and Supportive Care Domains to Improve Processes of Care and Patient Outcomes
  • Figures and Algorithms
    • ACC/AHA Stages of HF
    • Trajectory of Class C HF
    • Classification and Trajectories of HF Based on LVEF
    • Diagnostic Algorithm for HF and EF-Based Classification
    • Recommendations (Class 1 and 2a) for Patients at Risk of HF (Stage A) and Those With Pre-HF (Stage B)
    • Treatment of HFrEF Stages C and D
    • Additional Medical Therapies for Patients With HFrEF
    • Algorithm for CRT Indications in Patients With Cardiomyopathy or HFrEF
    • Additional Device Therapies
    • Treatment Approach in Secondary Mitral Regurgitation
    • Recommendations for Patients With Mildly Reduced LVEF (41%– 49%)
    • Recommendations for Patients With Preserved LVEF (≥50%)
    • Diagnostic and Treatment of Transthyretin Cardiac Amyloidosis Algorithm
    • Recommendations for Treatment of Patients With HF and Selected Comorbidities
    • A Depiction of the Clinical Course of HF With Associated Types and Intensities of Available Therapies Over Time
  • For purchases under 100 in quantity, we suggest placing the order directly through the website.
  • We offer group/institutional licenses for multi-user accounts (discount amount varies depending on the number of users).
  • We are proud to offer special discounts to medical schools, training programs, students and more.
  • We offer bulk purchase discounts based on number of copies and number of titles.

Contact Us for more details

The American College of Cardiology (ACC) continues to transform quality cardiovascular care and improve heart health after more than 60 years of existence through its mission, vision and values. The College is proud of its efforts to bring evidence-based clinical care into everyday practice.

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. AHA's Professional Membership is a made up of a robust group of cardiovascular professionals who participate in discovery and dissemination of science.

The Heart Failure Society of America, Inc. (HFSA) represents the first organized effort by heart failure experts from the Americas to provide a forum for all those interested in heart function, heart failure, and congestive heart failure (CHF) research...


This resource is for informational purposes only, intended as a quick-reference tool based on the cited source guideline(s), and should not be used as a substitute for the independent professional judgment of healthcare providers. Practice guidelines are unable to account for every individual variation among patients or take the place of clinician judgment, and the ultimate decision concerning the propriety of any course of conduct must be made by healthcare providers after consideration of each individual patient situation. Guideline Central does not endorse any specific guideline(s) or guideline recommendations and has not independently verified the accuracy hereof. Any use of this resource or any other Guideline Central resources is strictly voluntary.

You can also find this product included in these bundles!

Need help?